Search

Two-dimensional (2D) ultrasound can conveniently evaluate focal regions of interest intraorally. When a larger field of view to spatially reference remote anatomical structures is needed, 3D ultrasound (US) is desirable but not currently available. The aim of this study was to demonstrate the feasibility of constructing 3D US jawbone for ridge width determination.Seven porcine hemi-mandibles with the overlying soft tissues secured by a holding frame with fiducial markers were US scanned on the facial and lingual sides separately. The facial and lingual volumes were combined into a single volume, which was registered with the matched cone beam computed tomography (CBCT) scan. On 8 to 11 cross-sections, 4 measurements of the facio-lingual ridge width at 3, 6, 9 and 12 mm from the bone crest were performed by two calibrated examiners. A mixed model was used to estimate the differences between US and CBCT readings.Inter-examiner correlation was 0.978 and 0.987 for US and CBCT measurements, respectively. The ICCs between the US and CBCT was between 0.890 and 0.988 at the defined sites. The estimated mean differences ranged from -0.38 ± 0.69 (95% CI: -0.66 to -0.11) mm to 0.07 ± 0.93 (95% CI: -0.23 to 0.38) mm. The normalized root mean square deviation ranged between 4.50% and 7.89% for all levels except the 3 mm level, which ranged between 5.51% (in molars) and 11.16% (in premolars).This study demonstrates the feasibility of generating US jawbone in 3D for ridge width measurements.Commonly applied 2D ultrasound images are limited by a small field of view and an unknown coordinate system due to the nature of free hand scans. Novel 3D ultrasound acquisition enables referencing anatomical structures in a larger field of view and could become a promising tool to supplement CBCT.

Despite advances in medical therapies to help prevent the development of atherosclerosis and improve the management of patients with established peripheral arterial disease (PAD), the prevalence of PAD and associated morbidity remains high. Over the past decade, percutaneous revascularization therapies for the treatment of patients with PAD have evolved tremendously, and a great number of patients can now be offered treatment options that are less invasive than traditional surgical options. With the surgical approach, there is significant symptomatic improvement, but the associated morbidity and mortality preclude its routine use. Although newer percutaneous treatment options are associated with lower procedural complications, the technical advances have outpaced the evaluation of these treatments in adequately designed clinical studies, and therapeutic options are available that may not have been rigorously investigated. Therefore, for physicians treating patients with PAD, an understanding of the various therapies available, along with the inherent benefits and limitations of each treatment option is imperative as a greater number of patients with PAD are being encountered.

In its 16th year, the Transcatheter Cardiovascular Therapeutics (TCT) annual meeting remains one of the largest meetings in interventional cardiology. Live case demonstrations of interventional procedures remain a hallmark of this meeting, where results of several clinical studies and reviews of